Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-13T02:36:25.309Z Has data issue: false hasContentIssue false
  • English
  • Français

Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs

Published online by Cambridge University Press:  04 March 2009

E. Ephraim  and
R. Prettyman
E. Ephraim
Affiliation:
Bennion Centre, Glenfield Hospital, Leicestershire Partnership NHS Trust, Leicester, U.K.
R. Prettyman*
Affiliation:
Bennion Centre, Glenfield Hospital, Leicestershire Partnership NHS Trust, Leicester, U.K.
*
Correspondence should be addressed to: Dr. R. Prettyman, Leicestershire Partnership NHS Trust, Bennion Centre, Glenfield Hospital, Leicester LE3 9DZ, U.K. Phone: +44 (0)116 225 2752; Fax: +44 (0)116 2252770. Email: Richard.Prettyman@leicspart.nhs.uk.
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective: This study investigates attitudes to the prescription of mood stabilizer drugs for older patients by old age psychiatrists.

Methods: From a sample of 508 members of the Old Age Faculty of the Royal College of Psychiatrists practicing in England and Wales, 188 (37%) took part in a postal questionnaire survey. A proforma questionnaire investigating opinions about potential indications for, and current concerns about, mood stabilizer drugs was sent to all participants.

Results: Nearly all respondents initiated prescriptions for mood stabilizer drugs and a large majority agreed that they are therapeutically appropriate for prophylaxis of affective disorder (95%), treatment resistant depression (95%), acute mania (91%) and for behavioral symptoms in dementia (75%). Concerns about safety (77%), drug interactions (68%) and lack of scientific evidence (53%) were common.

Conclusions: Old age psychiatrists are frequent prescribers of mood stabilizer drugs for a variety of indications but have understandable concerns arising from a relative lack of scientific evidence of efficacy and effectiveness in older patients.

Keywords

mood stabilizerelderlylithiumcarbamazepinevalproatelamotrigine
Type
Research Article
Information
International Psychogeriatrics , Volume 21 , Issue 3 , June 2009 , pp. 576 - 580
Copyright
Copyright © International Psychogeriatric Association 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bazire, S. (2007). Psychotropic Drug Directory 2007. Aberdeen: Healthcomm U.K.Google Scholar
Committee on Safety of Medicines (2006). New Advice Issued on Risperidone and Olanzapine: Press Release. Available at http://www.mhra.gov.uk; last accessed 3 December 2007.Google Scholar
Ferrier, I. N. (2001). Developments in mood stabilizers, depression and public health. British Medical Bulletin, 57, 179–192.CrossRefGoogle Scholar
Grimm, S. W., Richtand, N. M., Winter, H. R., Stams, K. R. and Reele, S. B. (2006). Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. British Journal of Clinical Pharmacology 61, 58–69.CrossRefGoogle ScholarPubMed
Guthrie, S. K., Stoysich, A. M., Bader, G. and Hilleman, D. E. (1995). Hypothesized interaction between valproic acid and warfarin. Journal of Clinical Psychopharmacology, 15, 138–139.CrossRefGoogle ScholarPubMed
Johnson, G. (1998). Lithium: early development, toxicity and renal function. Neuropsychopharmacology, 19, 200–205.CrossRefGoogle ScholarPubMed
Katona, C. (2001). Psychotropics and drug interactions in the elderly patient. International Journal of Geriatric Psychiatry, 16 (Suppl. 1), 86–90.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
National Institute for Health and Clinical Excellence (2002). Clinical Guideline 1: Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Available at http://www.nice.org.uk/guidance; last accessed 7 December 2007.Google Scholar
National Institute for Health and Clinical Excellence (2007). Clinical Guideline 23 (amended): Depression: Management of Depression in Primary and Secondary Care. Available at http://www.nice.org.uk/guidance; last accessed 7 December 2007.Google Scholar
Sajatovic, M., Ramsay, E., Nanry, K. and Thompson, T. (2005). Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia. International Journal of Geriatric Psychiatry, 22; 10, 945–950.CrossRefGoogle Scholar
Shulman, K. I. et al. (2003). Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ, 326, 960–961.CrossRefGoogle ScholarPubMed
Sibbald, B., Addington-Hall, J., Brenneman, D. and Freeling, P. (1994). Telephone versus postal surveys of general practitioners: methodological considerations. British Journal of General Practice, 44, 297–300.Google ScholarPubMed